Jonathan Tegge
2023
In 2023, Jonathan Tegge earned a total compensation of $2.1K as Former Interim Chief Financial Officer at InMed Pharmaceuticals.
Compensation breakdown
| Option Awards | $2,100 |
|---|---|
| Total | $2,100 |
Tegge received $2.1K in option awards, accounting for 100% of the total pay in 2023.
Rankings
In 2023, Jonathan Tegge's compensation ranked 2,994th out of 3,006 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,994 out of 3,006 | 0th |
Division Manufacturing | 1,646 out of 1,650 | 0th |
Major group Chemicals And Allied Products | 916 out of 918 | 0th |
Industry group Drugs | 879 out of 881 | 0th |
Industry Pharmaceutical Preparations | 635 out of 637 | 0th |
Source: SEC filing on October 28, 2024.
Tegge's colleagues
We found four more compensation records of executives who worked with Jonathan Tegge at InMed Pharmaceuticals in 2023.
2023
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2023
Michael Woudenberg
InMed Pharmaceuticals
Chief Operating Officer
2023
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2023
Eric Hsu
InMed Pharmaceuticals